card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Insight

A Comprehensive Assessment of Onco-Panel Sequencing across Multiple Laboratories and Technologies

FDA-led Sequencing Quality Control Phase 2 (SEQC2) Consortium
Home / Insights / A Comprehensive Assessment of Onco-Panel Sequencing across Multiple Laboratories and Technologies

Onco-panel sequencing targets a very small portion of the genome and thus enables a detection of rare but clinically relevant mutations. Accurate diagnosis and subsequent therapy selection and tailoring depend on thorough and accurate characterization of tumor mutations. The lack of tumor reference samples, efficient panel validation processes, and standard practice guidelines is hindering the development of onco-panel sequencing and the realization of its benefits in cancer diagnosis and treatment.

Download this poster, presented at AMP 2019, to explore the methods, results, and conclusions of this study.

Complete the form below to access this scientific poster